Essex Bio-Technology Limited
HKEX:1061.HK
2.26 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q2 | 2011 Q4 | 2011 Q2 | 2010 Q2 | 2009 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 811.63 | 807.197 | 899.359 | 661.886 | 655.825 | 900.285 | 737.374 | 654.276 | 323.835 | 697.762 | 581.716 | 615.18 | 561.278 | 461.953 | 437.637 | 411.715 | 363.948 | 340.591 | 313.419 | 286.968 | 231.332 | 181.897 | 165.15 | 0 | 0 | 0 | 0 | 37.571 | 29.406 |
| Cost of Revenue
| 87.018 | 78.366 | 88.897 | 59.201 | 69.181 | 127.213 | 114.68 | 115.159 | 69.125 | 133.174 | 112.95 | 100.933 | 101.983 | 81.911 | 80.077 | 83.94 | 68.696 | 67.68 | 56.739 | 65.599 | 41.444 | 21.235 | 14.879 | 0 | 0 | 0 | 0 | 3.194 | 2.953 |
| Gross Profit
| 724.612 | 728.831 | 810.462 | 602.685 | 586.644 | 773.073 | 622.694 | 539.117 | 254.71 | 564.588 | 468.766 | 514.247 | 459.295 | 380.042 | 357.56 | 327.775 | 295.252 | 272.912 | 256.68 | 221.369 | 189.888 | 160.662 | 150.271 | 0 | 0 | 0 | 0 | 34.377 | 26.453 |
| Gross Profit Ratio
| 0.893 | 0.903 | 0.901 | 0.911 | 0.895 | 0.859 | 0.844 | 0.824 | 0.787 | 0.809 | 0.806 | 0.836 | 0.818 | 0.823 | 0.817 | 0.796 | 0.811 | 0.801 | 0.819 | 0.771 | 0.821 | 0.883 | 0.91 | 0 | 0 | 0 | 0 | 0.915 | 0.9 |
| Reseach & Development Expenses
| 12.479 | 18.895 | 20.25 | 11.902 | 11.606 | 12.443 | 11.08 | 5.617 | 2.96 | 2.291 | 1.117 | 13.076 | 5.367 | 3.076 | 3.355 | 2.718 | 2.934 | 6.733 | 5.33 | 1.149 | 5.884 | 2.147 | 4.414 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 115.69 | 101.277 | 76.413 | 79.564 | 84.695 | 69.061 | 65.863 | 45.749 | 47.505 | 34.219 | 44.005 | 24.904 | 23.048 | 17.357 | 27.278 | 20.681 | 26.937 | 24.221 | 20.524 | 21.844 | 14.68 | 10.894 | 0 | 0 | 0 | 0 | 3.646 | 3.382 |
| Selling & Marketing Expenses
| 0 | 491.333 | 520.663 | 394.405 | 363.808 | 458.674 | 377.28 | 313.093 | 163.537 | 332.136 | 300.684 | 336.962 | 312.757 | 267.463 | 247.835 | 207.853 | 202.686 | 183.452 | 168.657 | 141.52 | 129.846 | 109.044 | 102.958 | 0 | 0 | 0 | 0 | 22.586 | 16.829 |
| SG&A
| 547.896 | 582.005 | 601.69 | 462.828 | 430.023 | 533.452 | 435.646 | 370.672 | 207.792 | 375.755 | 334.135 | 380.967 | 337.661 | 290.511 | 265.192 | 235.131 | 223.367 | 210.389 | 192.878 | 162.044 | 151.69 | 123.724 | 113.852 | 0 | 0 | 0 | 0 | 26.232 | 20.211 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 560.375 | 600.899 | 621.94 | 474.73 | 441.629 | 545.895 | 446.726 | 376.289 | 210.752 | 378.045 | 335.252 | 359.901 | 336.513 | 274.197 | 263.476 | 232.083 | 222.468 | 205.864 | 191.299 | 161.116 | 150.785 | 122.291 | 113.752 | 0 | 0 | 0 | 0 | 26.067 | 20.185 |
| Operating Income
| 164.237 | 127.932 | 188.522 | 127.955 | 145.015 | 227.178 | 175.968 | 162.828 | 43.958 | 186.543 | 133.514 | 152.896 | 122.782 | 105.504 | 94.084 | 91.918 | 72.784 | 65.148 | 67.281 | 60.253 | 39.103 | 38.371 | 36.519 | 0 | 0 | 0 | 0 | 8.31 | 6.268 |
| Operating Income Ratio
| 0.202 | 0.158 | 0.21 | 0.193 | 0.221 | 0.252 | 0.239 | 0.249 | 0.136 | 0.267 | 0.23 | 0.249 | 0.219 | 0.228 | 0.215 | 0.223 | 0.2 | 0.191 | 0.215 | 0.21 | 0.169 | 0.211 | 0.221 | 0 | 0 | 0 | 0 | 0.221 | 0.213 |
| Total Other Income Expenses Net
| 35.093 | 14.29 | 16.912 | -30.12 | 17.686 | -15.795 | 7.106 | 30.237 | 13.832 | 15.442 | 16.266 | -1.483 | -1.141 | 0.095 | -2.637 | -2.24 | -0.224 | 1.279 | -3.057 | -1.861 | -1.74 | -0.791 | -1.037 | 0 | 0 | 0 | 0 | -0.004 | -0.007 |
| Income Before Tax
| 199.33 | 142.222 | 205.434 | 97.836 | 162.701 | 211.383 | 183.074 | 193.065 | 57.79 | 201.985 | 149.78 | 151.413 | 121.641 | 105.599 | 91.447 | 89.678 | 72.56 | 66.427 | 64.224 | 58.392 | 37.363 | 37.58 | 35.482 | 0 | 0 | 0 | 0 | 8.306 | 6.261 |
| Income Before Tax Ratio
| 0.246 | 0.176 | 0.228 | 0.148 | 0.248 | 0.235 | 0.248 | 0.295 | 0.178 | 0.289 | 0.257 | 0.246 | 0.217 | 0.229 | 0.209 | 0.218 | 0.199 | 0.195 | 0.205 | 0.203 | 0.162 | 0.207 | 0.215 | 0 | 0 | 0 | 0 | 0.221 | 0.213 |
| Income Tax Expense
| 39.94 | 35.711 | 35.044 | 11.461 | 23.47 | 27.601 | 20.888 | 23.327 | 8.602 | 29.058 | 20.205 | 19.237 | 22.725 | 15.42 | 14.327 | 15.381 | 10.573 | 13.174 | 12.582 | 13.707 | 6.775 | 9.556 | 8.609 | 0 | 0 | 0 | 0 | 1.487 | 1.15 |
| Net Income
| 157.44 | 105.449 | 169.811 | 86.18 | 139.231 | 183.782 | 162.186 | 169.738 | 49.188 | 172.927 | 129.575 | 132.176 | 98.916 | 90.179 | 77.12 | 74.297 | 61.987 | 53.253 | 51.642 | 44.685 | 30.588 | 28.024 | 26.873 | 0 | 0 | 0 | 0 | 6.819 | 2.897 |
| Net Income Ratio
| 0.194 | 0.131 | 0.189 | 0.13 | 0.212 | 0.204 | 0.22 | 0.259 | 0.152 | 0.248 | 0.223 | 0.215 | 0.176 | 0.195 | 0.176 | 0.18 | 0.17 | 0.156 | 0.165 | 0.156 | 0.132 | 0.154 | 0.163 | 0 | 0 | 0 | 0 | 0.181 | 0.099 |
| EPS
| 0.28 | 0.19 | 0.3 | 0.15 | 0.24 | 0.32 | 0.28 | 0.29 | 0.085 | 0.3 | 0.22 | 0.22 | 0.17 | 0.16 | 0.14 | 0.13 | 0.11 | 0.093 | 0.092 | 0.08 | 0.055 | 0.05 | 0.048 | 0 | 0 | 0 | 0 | 0.01 | 0.005 |
| EPS Diluted
| 0.27 | 0.18 | 0.28 | 0.15 | 0.23 | 0.31 | 0.27 | 0.28 | 0.085 | 0.29 | 0.21 | 0.22 | 0.16 | 0.16 | 0.14 | 0.13 | 0.11 | 0.093 | 0.092 | 0.08 | 0.055 | 0.05 | 0.048 | 0 | 0 | 0 | 0 | 0.01 | 0.005 |
| EBITDA
| 190.537 | 156.414 | 219.549 | 149.187 | 165.31 | 243.532 | 192.185 | 177.046 | 56.967 | 200.759 | 146.717 | 162.437 | 132.332 | 116.87 | 100.489 | 99.275 | 78.197 | 70.136 | 72.334 | 65.322 | 43.89 | 40.162 | 37.184 | 0 | 0 | 0 | 0 | 8.31 | 6.268 |
| EBITDA Ratio
| 0.235 | 0.194 | 0.244 | 0.225 | 0.252 | 0.271 | 0.261 | 0.271 | 0.176 | 0.288 | 0.252 | 0.264 | 0.236 | 0.253 | 0.23 | 0.241 | 0.215 | 0.206 | 0.231 | 0.228 | 0.19 | 0.221 | 0.225 | 0 | 0 | 0 | 0 | 0.221 | 0.213 |